Iovance Biotherapeutics Inc. Common Stock vs Permian Resources Corporation Class A Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.44 (market cap $5.85B), while Permian Resources Corporation Class A Common Stock trades at $22.64 (market cap $18.57B). The key difference: Permian Resources Corporation Class A Common Stock is far larger — about 3.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Permian Resources Corporation Class A Common Stock pays a 2.84% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Permian Resources Corporation Class A Common Stock for 0 Days on average.
| IOVA | PR | |
|---|---|---|
Market Cap | $5.85B | $18.57B |
Volume | 14,517,176 | 7,560,985 |
Sector | Health | Energy |
52-Week High | $14.82 | $24.49 |
52-Week Low | $1.81 | $12.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.78B | $21.57B |
Dividend Yield | — | 2.84% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Permian Resources explores for and produces oil and natural gas in the Permian Basin. Its operations are concentrated in the Delaware Basin of West Texas and New Mexico.
Read more on PR →